Search Results

• • 8 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis

  Authors:Agustin A. Garcia, Syma Iqbal, David Quinn, Susan Edwards, Heinz Josef Lenz, and Jeff WeberFrom:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1460L

   Citation Only

• Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas

  Authors:H.W.M. van Laarhoven, G. Gambarota, A. Heerschap, J. Lok, I. Verhagen, A. Corti, et al.From:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1640L

   Citation Only

• A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma

  Authors:Karl D. Lewis, John A. Thompson, Jeffrey S. Weber, William A Robinson, Steven O'Day, Jose Lutzky, et al.From:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1410L

   Citation Only

• From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates

  Author:Jackie WallingFrom:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Article 1610L

   Citation Only

• In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis[R], Trabectidin[R]), a novel marine anti-cancer drug

  Authors:Esther F.A. Brandon, Rolf W. Sparidans, Kess-Jan Guijt, Sjoerd Lowenthal, Irma Meijerman, Jos H. Beijnen, et al.From:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1520L

   Citation Only

• Phase II trial of imatinib (Gleevec[R]) in patients with metastatic renal cell carcinoma

  Authors:Jacqueline Vuky, Christina Isacson, Mehran Fotoohi, Jason dela Cruz, Henry Otero, Vincent Picozzi, et al.From:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1460L

   Citation Only

• From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.

  Author:Jackie WallingFrom:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 200634 words Report, Brief articl...

   Abstract Only

• The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro

  Authors:Dragana Jankovic, Milica Pesic, Jasna Markovic, Selma Kanazir, Ivanka Markovic, Ljubisav Rakic, et al.From:Investigational New Drugs (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 2006 Clinical report 1540L

   Citation Only